Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06MNW
|
|||
| Former ID |
DNC004648
|
|||
| Drug Name |
1-(oxazol-2-yl)octadec-9-en-1-one
|
|||
| Synonyms |
CHEMBL39412; 1-(oxazol-2-yl)octadec-9-en-1-one; SCHEMBL13764125; BDBM50100864; AKOS030561890; 1-Oxazol-2-yl-nonadec-10-en-2-one; (Z)-1-Oxazol-2-yl-octadec-9-en-1-one; (Z)-1-(oxazol-2-yl)octadec-9-en-1-one; (9Z)-1-(2-Oxazolyl)-9-octadecene-1-one
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H35NO2
|
|||
| Canonical SMILES |
CCCCCCCCC=CCCCCCCCC(=O)C1=NC=CO1
|
|||
| InChI |
1S/C21H35NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-22-18-19-24-21/h9-10,18-19H,2-8,11-17H2,1H3/b10-9-
|
|||
| InChIKey |
WWYUNXGFLPTVRR-KTKRTIGZSA-N
|
|||
| CAS Number |
CAS 288862-40-8
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Aug 14;51(15):4392-403. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.